Search Results 1021-1030 of 17577 for Assay

  1. Skin Cancer Clinical Trials - Mayo Clinic Research

    The primary objective of this collaborative study is to collect biospecimens for the evaluation of internally developed assays designed to predict for and ...

  2. Study to Evaluate the Effectiveness and Safety of Remdesivir in Participants with Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 - Mayo Clinic

    ... assay (e.g., Nucleic Acid Amplification Test [NAAT] and antigen tests) in any respiratory specimen. Hospitalized for COVID-19. Age ≥ 12 years and weighing ...

  3. Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers - Mayo Clinic

    ... assay; 4. Failed or been intolerant of prior lines of systemic therapy; 5. Estimated life expectancy > 4 months; 6. At least 1 measurable lesion per RECIST ...

  4. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    ... assay (e.g., Nucleic Acid Amplification Test [NAAT], antigen test) in any respiratory specimen, or saliva 5 times the upper limit of normal. Illness of any ...

  5. A Study of the Safety And Effectiveness of Palbociclib Plus Cetuximab versus Cetuximab Alone to Treat Head and Neck Cancer - Mayo Clinic

    ... assays); Documented progressive disease according to RECIST v1.1 following receipt of at least 2 cycles of one platinum-containing chemotherapy regimen ...

  6. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    ... assay is to be submitted, preferably from the same time of collection as that evaluated by the designated outside laboratory. Patient must not require the ...

  7. A Study to Evaluate the Effectiveness of M7824 Monotherapy in Locally Advanced or Metastatic Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - Mayo Clinic

    The purpose of this study is to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant ...

  8. Panel of methylated DNA markers provides improved accuracy in detecting advanced neoplasia and other lesions that may require resection

    From a pool of 25 discriminant MDMs discovered in tissue, the researchers identified 13 that were chosen for a pilot study in 134 cyst fluid assays using ...

  9. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

    Free light chain (FLC) assay with involved FLC level ≥10 mg/dL with an abnormal serum FLC ratio - A patient with Immunoglobulin A (IgA) myeloma but without ...

  10. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

    TNBC is defined as negative immunohistochemistry (IHC) assays for Estrogen Receptor (ER), and Progesterone Receptor (PR), and HER2 negative (IHC 0 or 1+, or 2+ ...